美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72603-146-01	72603-146	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride	Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230428	N/A	ANDA	ANDA214533	NorthStar Rx LLC	LABETALOL HYDROCHLORIDE	5 mg/mL	1 VIAL, MULTI-DOSE in 1 CARTON (72603-146-01) / 20 mL in 1 VIAL, MULTI-DOSE
65145-125-01	65145-125	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride	Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20250214	N/A	ANDA	ANDA214533	Caplin Steriles Limited	LABETALOL HYDROCHLORIDE	5 mg/mL	1 VIAL, MULTI-DOSE in 1 CARTON (65145-125-01) / 40 mL in 1 VIAL, MULTI-DOSE
65145-124-01	65145-124	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride	Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20250214	N/A	ANDA	ANDA214533	Caplin Steriles Limited	LABETALOL HYDROCHLORIDE	5 mg/mL	1 VIAL, MULTI-DOSE in 1 CARTON (65145-124-01) / 20 mL in 1 VIAL, MULTI-DOSE
25021-317-20	25021-317	HUMAN PRESCRIPTION DRUG	labetalol hydrochloride	labetalol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220901	N/A	ANDA	ANDA214533	Sagent Pharmaceuticals	LABETALOL HYDROCHLORIDE	5 mg/mL	1 VIAL in 1 CARTON (25021-317-20) / 20 mL in 1 VIAL
25021-317-40	25021-317	HUMAN PRESCRIPTION DRUG	labetalol hydrochloride	labetalol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220901	N/A	ANDA	ANDA214533	Sagent Pharmaceuticals	LABETALOL HYDROCHLORIDE	5 mg/mL	1 VIAL in 1 CARTON (25021-317-40) / 40 mL in 1 VIAL